In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission. Ben ...

Illumina chief executive Francis deSouza confirmed in a LinkedIn post today that he has handed in his resignation, ending a seven-year stint at the helm of the gene-sequencing giant and 10 years on ...

If you are looking at Illumina and wondering whether today’s price really reflects its long term potential, you are not alone; this stock has gone from market darling to question mark and back again ...

Like nearly all biological mechanisms, small RNA-directed pathways are both elegantly simple — small RNA guides use sequence complementarity to identify their targets — and shockingly complex, with ...

The transcriptome is the complete set of transcripts in a cell, and their quantity, for a specific developmental stage or physiological condition. Understanding the transcriptome is essential for ...

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the ...